abagovomab 0
abciximab 11
abituzumab 3
abrilumab 0
actoxumab 3
adalimumab 7
aducanumab 0
afasevikumab 0
alacizumab_pegol 0
alemtuzumab 8
alirocumab 0
amatuximab 7
andecaliximab 0
anifrolumab 3
anrukinzumab 5
aprutumab 3
aprutumab_ixadotin 3
arcitumomab 4
ascrinvacumab 0
atezolizumab 4
atinumab 9
avelumab 3
basiliximab 0
bavituximab 5
begelomab 0
benralizumab 6
bevacizumab_beta 0
bezlotoxumab 3
bimagrumab 3
bleselumab 0
blinatumomab 9
blosozumab 8
bococizumab 6
brazikumab 0
brentuximab_vedotin 0
briakinumab 4
brodalumab 0
brolucizumab 10
brontictuzumab 3
burosumab 4
cabiralizumab 3
camrelizumab 0
canakinumab 3
cantuzumab_ravtansin 10
carlumab 3
carotuximab 0
cergutuzumab_amunaleukin2 11
cergutuzumab_amunaleukin 11
certolizumab_pegol 0
cetiximab 10
citatuzumab_bogatox 10
cixutumumab 8
clivatuzumab_tetraxetan 4
codrituzumab 10
conatumumab 3
concizumab 3
crenezumab 3
crizanlizumab 3
crotedumab 5
dacetuzumab 8
daclizumab 5
dalotuzumab 6
dapirolizumab_pegol 5
daratumumab 7
dectrekumab 3
demcizumab 7
denosumab 3
depatuxizumab 3
depatuxizumab_mafodotin 3
dezamizumab 0
dinutuximab 7
diridavumab 0
domagrozumab 0
drozitumab 0
duligotuzumab 6
durvalumab 0
dusigitumab 0
efalizumab 13
efungumab 0
eldelumab 3
elezanumab 0
elgemtumab 0
elotuzumab 0
emactuzumab 4
emapalumab 6
emibetuzumab 0
enavatuzumab 7
enfortumab_vedotin 0
enoblituzumab 0
enokizumab 0
enoticumab 3
ensituximab 6
eptinezumab 0
erenumab 3
etaracizumab 7
etrolizumab 13
evinacumab 4
evolocumab 3
farletuzumab 0
fasinumab 3
fezakinumab 0
fibatuzumab 0
ficlatuzumab 0
firivumab 8
flanvotumab 0
fletikumab 4
foralumab 0
foravirumab 3
fremanezumab 9
fresolimumab 9
fulranumab 10
futuximab 3
galcanezumab 0
ganitumab 8
gantenerumab 0
gemetuzumab 9
gemtuzumab2 7
gemtuzumab 6
gevokizumab 11
girentuximab 5
glembatumumab 6
glembatumumab_vedotin 6
guselkumab 11
ibalizumab 9
ibritumomab 0
icrucumab 0
idarucizumab 3
ifabotuzumab 0
imalumab 7
imgatuzumab 5
inclacumab 4
indatuximab_ravtansin 9
indusatumab 5
inebilizumab 5
intetumumab 3
iodine_girentuximab 6
ipilimumab 0
iratumumab 0
isatuximab 0
itolizumab 0
ixekizumab 6
labetuzumab_govitecan 8
lambrolizumab 6
lampalizumab 4
lanadelumab 8
landogrozumab 0
laprituximab 3
lebrikizumab 11
lendalizumab 5
lenzilumab 3
lifastuzumab_vedotin 0
ligelizumab 5
lilotomab 10
lirilumab 0
lodelcizumab 6
lokivetmab 3
lorvotuzumab_mertansin 0
lucatumumab 3
lumretuzumab 0
lupartumab 0
lutikizumab 9
margetuximab 9
milatuzumab 3
mirvetuximab 11
mirvetuximab_soravtansin 11
modotuximab 8
mogamulizumab 8
monalizumab 10
motavizumab 7
moxetumomab_pasudotox 7
namilumab 0
naratuximab 4
naratuximab_emtansin 4
narnatumab 7
navicixizumab2 11
navicixizumab 7
navivumab 3
necitumumab 0
nemolizumab 7
nesvacumab 0
nivolumab 3
obiltoxaximab 0
obinutuzumab 10
ocaratuzumab 9
ofatumumab 0
olaratumab 0
olokizumab 9
omalizumab 7
onartuzumab 6
ontuxizumab 0
opicinumab 9
orticumab 0
otelixizumab 6
oxelumab 0
ozanezumab 3
pamrevlumab 0
panobacumab 3
parsatuzumab 9
pasotuxizumab 7
pateclizumab 5
patritumab 4
pembrolizumab 6
perakizumab 0
pidilizumab 3
pinatuzumab_vedotin 0
plozalizumab 4
pogalizumab 0
polatuzumab_vedotin 7
ponezumab 6
prezalumab 7
pritoxaximab 8
quilizumab 4
racotumomab 6
radretumab 0
ralpancizumab 8
ramucirumab 3
ranevetmab 9
ranibizumab 0
refanezumab 3
remtolumab 5
rilotumumab 3
rinucumab 0
risankizumab 3
rituximab 0
rivabazumab 6
robatumumab 10
roledumab 5
romosozumab 3
rontalizumab 6
rosmantuzumab 3
rozanolixizumab 4
sacituzumab 6
sacituzumab_govitecan 6
samalizumab 6
sapelizumab 5
sarilumab 0
secukinumab 0
seribantumab 0
setoxaximab 9
sifalimumab 0
siltuximab 7
simtuzumab 8
sirukumab 6
solanezumab 10
solitomab 3
stamulumab 0
suptavumab 4
suvizumab 0
tabalumab 0
tadocizumab 0
tamtuvetmab 4
tanezumab 12
tarextumab 3
tavolixizumab 0
telisotuzumab 9
teplizumab 6
tesidolumab 0
tezepelumab 4
tigatuzumab 9
tildrakizumab 6
timolumab 0
tisotumab 0
tosatoxumab 11
tositumomab 0
tralokinumab 11
trastuzumab 7
tregalizumab 7
trevogrumab 5
ublituximab 3
urelumab 0
ustekinumab 7
utomilumab 3
vadastuximab 0
vadastuximab_talirin 0
vandortuzumab_vedotin 0
vantictumab 4
vanucizumab2 0
vanucizumab 4
varlilumab 3
vatelizumab 7
vedolizumab 0
veltuzumab 0
vesencumab 0
vorsetuzumab 3
vorsetuzumab_mafodotin 3
vunakizumab 5
xentuzumab 0
zatuximab 8
